Clinical response and serum gold levels in chrysotherapy. Lack of correlation.-Reference-Cited by-同舟云学术

Clinical response and serum gold levels in chrysotherapy. Lack of correlation.

Published:1972-07-01 Issue:4 Volume:31 Page:308-310
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Annals of the Rheumatic Diseases

Author:

Gerber R C,Paulus H E,Bluestone R,Pearson C M

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference11 articles.

1. Arthr;American Rheumatism Association;and Rheum; Revision of Diagnostic Criteria for Rheumatoid Arthritis,1959

2. FINCH, C. A. (1949) J. clin. Invest., 28, 780 (Iron metabolism in hemochromatosis)

3. Arthritis and Allied Conditions;FREYBERG, R.H.,1966

4. J. clin;BLOCK, W.D.; LEvEY, S.;Invest; Metabolism toxicity and manner of action of gold compounids used in the treatment of arthritis. I. Human plasma and synovial fluid concentrations and urinary excretion of gold during and following treatment with gold sodium thiomalate, gold sodium thiosulfate and colloidal gold sulfide,1941

5. (Gold excretion and clinical status of rheumatoid arthritic patients on chrysotherapy);BLOCK, W.D.; LEvEY, S.,1971

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gold and Gold mining;Handbook on the Toxicology of Metals;2022

2. Gold and Female Reproductive Organs: an Ultrastructural Study;Biological Trace Element Research;2017-08-24

3. Gold and Gold Mining;Handbook on the Toxicology of Metals;2015

4. Aurothiomalate inhibits the expression of mPGES-1 in primary human chondrocytes;Scandinavian Journal of Rheumatology;2014-10-14

5. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs;Arthritis & Rheumatism;2010-02-22